AstraZeneca International is one of the world's leading pharmaceutical companies producing quality prescription drugs and medicines. AstraZeneca was formed on 6 April 1999 through the merger of Astra AB of Sweden and Zeneca Group PLC of the UK.
AstraZeneca aims to discover new medicines to improve the health and quality of life of patients around the world. Their medicines are innovative, effective and offer added benefits such as reduced side effects or better ways of taking the treatment. The company also focuses on getting the best from every medicine, by exploring all the ways it can be used or improved . The mission of AstraZeneca is to deliver long term growth and enduring shareholder value through:
- Global power & reach in sales and marketing
- Stronger R&D platform for innovation-led growth
- Greater financial strategic flexibility
The areas of operation or main businesses of AstraZeneca are:
Health Care:- Respiratory and Inflammation Therapy
- Infection Therapy
- Oncology Therapy
- Cardiovascular Therapy
- Neuroscience Therapy
- Gastrointestinal Therapy
- AstraTech
- Aptium Oncology (formerly Salick Health Care)
Key Statistics
- AstraZeneca holds assets of $23.72 billions.
- Profits made by AstraZeneca in 2006 amounts to $4.46 billions.
- AstraZeneca operates in countries of Europe, North and Central America, Latin America, Africa, Pacific, Asia and Middle East.
- In total, AstraZeneca employs over 65,000 people worldwide.
Organizational Structure
The organization consists of:
- The Board
- Senior Executive Team
- Audit Committee
- Remuneration Committee
- Nomination Committee
- Science Committee
International Ranking
- AstraZeneca ranks 253 in the world according to the Fortune Global 500 list.
- The Forbes Magazine has ranked AstraZeneca 167 in the world in 2006.
The company has R&D centers and manufacturing sites in many parts of the world.
Headquarter Address
15 Stanhope GateLondon W1K 1LN
United Kingdom
Phone: 44-20-7304-5000
Website URL: www.astrazeneca.com
